MiniMed Group, Inc. Common Stock
MMED
Rang in aandelen
#3402
MiniMed Group, Inc. specializes in designing, producing, and distributing a... MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Aandeelprijs
$17.84
Marktkapitalisatie
$5.02B
Verandering (1 dag)
0.22%
Verandering (1 jaar)
-
Land
US
Handel MiniMed Group, Inc. Common Stock (MMED)
Categorie
Healthcare
Dividendrendementgeschiedenis voor MiniMed Group, Inc. Common Stock (MMED)
Het dividendrendement (TTM) van MiniMed Group, Inc. Common Stock (aandelsymbool: MMED) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van MiniMed Group, Inc. Common Stock (MMED) van 2023 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
| Jaar | Dividendrendement | Wijzigen |
|---|---|---|
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
| Bedrijf | Dividendrendement | Land |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
IL
|
|
| 0.51% |
US
|
